Orly Mishan is Chief Business Officer of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 38,450 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Jan 26, 2021, when has been sold 38,450 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $134,575. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.5K
0% 3M change
0% 12M change
Total Value Held $0

ORLY MISHAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2021
BUY
Exercise of conversion of derivative security
$134,575 $3.5 p/Share
38,450 Added 50.0%
38,450 Common Stock
OM

Orly Mishan

Chief Business Officer
Cambridge, MA

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Track Activities on CERE